Crossmark

IDH enzyme inhibition in cancer therapy: mechanisms, mutational insights, and effects of IDH inhibitors in glioma, acute myeloid leukemia and chondrosarcoma

Crossref DOI link: https://doi.org/10.1007/s13205-026-04753-8

Published Online: 2026-03-10

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Josephine, Anthony https://orcid.org/0000-0002-5474-0034
Kumar, Sekar Ashok

Sureka, Varalakshmi

Rajendran, Peramaiyan
License Information

Text and Data Mining valid from 2026-03-10

Version of Record valid from 2026-03-10
More Information

Article History

Received: 30 July 2025

Accepted: 17 February 2026

First Online: 10 March 2026

Declarations

:

: All the authors declare that there is no conflict of interest in the content of this article.

Document is current

Any future updates will be listed below